These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1340 related articles for article (PubMed ID: 19064967)

  • 1. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
    Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B
    J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.
    de Jong RA; Leffers N; Boezen HM; ten Hoor KA; van der Zee AG; Hollema H; Nijman HW
    Gynecol Oncol; 2009 Jul; 114(1):105-10. PubMed ID: 19411095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer.
    Giatromanolaki A; Bates GJ; Koukourakis MI; Sivridis E; Gatter KC; Harris AL; Banham AH
    Gynecol Oncol; 2008 Aug; 110(2):216-21. PubMed ID: 18533240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.
    Pagès F; Kirilovsky A; Mlecnik B; Asslaber M; Tosolini M; Bindea G; Lagorce C; Wind P; Marliot F; Bruneval P; Zatloukal K; Trajanoski Z; Berger A; Fridman WH; Galon J
    J Clin Oncol; 2009 Dec; 27(35):5944-51. PubMed ID: 19858404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
    Kiniwa Y; Miyahara Y; Wang HY; Peng W; Peng G; Wheeler TM; Thompson TC; Old LJ; Wang RF
    Clin Cancer Res; 2007 Dec; 13(23):6947-58. PubMed ID: 18056169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?
    Jordanova ES; Gorter A; Ayachi O; Prins F; Durrant LG; Kenter GG; van der Burg SH; Fleuren GJ
    Clin Cancer Res; 2008 Apr; 14(7):2028-35. PubMed ID: 18381941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma.
    Watanabe Y; Katou F; Ohtani H; Nakayama T; Yoshie O; Hashimoto K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):744-52. PubMed ID: 20303300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of tumor-infiltrating lymphocytes for survival in curatively resected stage IV colon cancer with isolated liver or lung metastasis.
    Lee WS; Kang M; Baek JH; Lee JI; Ha SY
    Ann Surg Oncol; 2013 Feb; 20(2):697-702. PubMed ID: 23224827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner.
    Yuan XL; Chen L; Li MX; Dong P; Xue J; Wang J; Zhang TT; Wang XA; Zhang FM; Ge HL; Shen LS; Xu D
    Clin Immunol; 2010 Mar; 134(3):277-88. PubMed ID: 19900843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes.
    Liu F; Lang R; Zhao J; Zhang X; Pringle GA; Fan Y; Yin D; Gu F; Yao Z; Fu L
    Breast Cancer Res Treat; 2011 Nov; 130(2):645-55. PubMed ID: 21717105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma.
    Mathai AM; Kapadia MJ; Alexander J; Kernochan LE; Swanson PE; Yeh MM
    Am J Surg Pathol; 2012 Jul; 36(7):980-6. PubMed ID: 22446942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour-infiltrating lymphocytes and survival in patients with adenocarcinoma of the oesophagus.
    Zingg U; Montani M; Frey DM; Dirnhofer S; Esterman AJ; Went P; Oertli D
    Eur J Surg Oncol; 2010 Jul; 36(7):670-7. PubMed ID: 20510571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral FOXP3 expression in infiltrating breast carcinoma: Its association with clinicopathologic parameters and angiogenesis.
    Gupta S; Joshi K; Wig JD; Arora SK
    Acta Oncol; 2007; 46(6):792-7. PubMed ID: 17653902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.
    Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; Du Z
    Digestion; 2012; 86(4):329-37. PubMed ID: 23207161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased number of CD25 FoxP3 regulatory T cells in oral squamous cell carcinomas detected by chromogenic immunohistochemical double staining.
    Schwarz S; Butz M; Morsczeck C; Reichert TE; Driemel O
    J Oral Pathol Med; 2008 Sep; 37(8):485-9. PubMed ID: 18355177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells.
    Ladoire S; Arnould L; Apetoh L; Coudert B; Martin F; Chauffert B; Fumoleau P; Ghiringhelli F
    Clin Cancer Res; 2008 Apr; 14(8):2413-20. PubMed ID: 18413832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.
    Gao Q; Qiu SJ; Fan J; Zhou J; Wang XY; Xiao YS; Xu Y; Li YW; Tang ZY
    J Clin Oncol; 2007 Jun; 25(18):2586-93. PubMed ID: 17577038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma.
    Anraku M; Cunningham KS; Yun Z; Tsao MS; Zhang L; Keshavjee S; Johnston MR; de Perrot M
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):823-9. PubMed ID: 18374762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.